Overview

A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis

Status:
Unknown status
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and the safety of preoperative chemotherapy with Gemcitabine/ Cisplatin /S-1 for biliary tract cancers with lymph node metastasis by FDG-PET.
Phase:
Phase 2
Details
Lead Sponsor:
Kansai Hepatobiliary Oncology Group
Treatments:
Cisplatin
Gemcitabine